Morningstar

PharmaJet®, a World Leader in Needle-Free Injection Systems, is Initiating the Development of Needle-Free Self-Injection Pens for Home Use

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...
Morningstar

PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...